New scanner aims to sharpen cancer radiation targeting
NCT ID NCT06187103
First seen Jan 06, 2026 · Last updated May 15, 2026 · Updated 21 times
Summary
This study tests a new imaging system called HyperSight that takes clearer, faster 3D scans during radiation therapy for cancer. The goal is to see if these scans are good enough to help doctors plan treatment more accurately. About 40 adults with head and neck, breast, lung, upper GI, or pelvic cancer will participate. If successful, this could reduce damage to healthy tissue and improve treatment precision.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Maryland Medical Center
Baltimore, Maryland, 21201-1544, United States
Conditions
Explore the condition pages connected to this study.